Understanding the experiences of young adults with severe asthma

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore the lived experiences and support needs of young adults aged 16-25 who suffer from severe and uncontrolled asthma. Through in-depth one-on-one interviews utilizing photo elicitation techniques, participants will share their daily challenges and experiences related to asthma management. Additionally, focus groups will be conducted to further identify support needs and inform future interventions. The study seeks to develop a comprehensive understanding of this demographic's unique needs to improve care and outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* A confirmed diagnosis of severe or uncontrolled asthma under the care of the Manchester or Liverpool severe asthma services
* Participants aged 16-25 years.
* Informed consent provided.

Exclusion Criteria:

* Inability to provide informed consent.
* Participants with additional long-term conditions who identify their dominant health concern to be non-asthma related.
* Focus group only- inability to converse in English

Where it's running

• Severe asthma services based at both Manchester University Foundation NHS trust and Liverpool University Foundation NHS Trust
  Manchester, Greater, United Kingdom Recruiting

Study contacts

• Study coordinator: Leanne - Jo Holmes, Mres
• Email: leannejo.holmes@mft.nhs.uk
• Phone: +44 01619987070

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Exercise program for adults with severe asthma starting biologics

  A tailored exercise program is being tested to see if it helps adults with severe asthma who are starting biologic therapy feel better and breathe better.

  Recruiting Helsinki University Central Hospital · Helsinki · NCT07655037

• Predicting response to Benralizumab in severe asthma patients

  This study is testing if a specific blood test can help predict how well people with severe asthma will respond to the medication Benralizumab.

  Recruiting at 15 sites Phase 4 Nantes University Hospital · Aix-en-Provence and 19 other locations · NCT04565483

• Chronic Respiratory Disease Participant Engagement

  This study tests whether adults with long-term lung conditions can get comfortable with a clinical trials unit and research team before joining future trials.

  Recruiting Richmond Pharmacology Limited · London · NCT07924462

• HB0056 in adults with moderate to severe asthma

  This study tests HB0056 versus a placebo to see if it helps adults with moderate to severe asthma reduce rescue inhaler use and improve symptoms.

  Recruiting at 2 sites Phase 1/2 Shanghai Huaota Biopharmaceutical Co., Ltd. · Beijing and 1 other locations · NCT07899996

• Tilrekimig (PF-07275315) for Severe Asthma: Aimed at Adults with Frequent Exacerbations

  This study tests whether tilrekimig helps people with severe asthma who have had multiple flare-ups in the past year, by comparing it to a placebo given every four weeks.

  Recruiting at 4 sites Phase 3 Pfizer · River Forest, Illinois and 11 other locations · NCT07869043

• Inhaled CHF10136 safety and pharmacokinetics in healthy adults and adults with asthma

  This first-in-human study tests inhaled CHF10136 to see if it is safe and well tolerated, how it behaves in the body, and how it affects adults with asthma compared with placebo.

  Recruiting Phase 1 Chiesi Farmaceutici S.p.A. · Leeds and 2 other locations · NCT07851623

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.